Finally Drug the “Undruggable” Through Targeted Protein Degradation
As the most comprehensive, industry-focused and ‘must-attend’ event in the field, the 4th Targeted Protein Degradation Summit returns to once again explore the latest approaches, perspectives, and data-drive case studies that will continue to advance PROTACs, molecular glues, and other degrader modalities towards clinical success.
With 70+ world-class speakers and over 500 senior attendees from around the globe, join the largest community of protein degradation experts for a deep dive into clinical development progress, lessons learnt and novel strategies to develop safe, selective and effective PROTACs, molecular glues, lysosomal degradation, autophagy-mediated degraders as well as uncovering novel degrader modalities and approaches for oncology and beyond.
Check out the preliminary agenda for a sneak preview of our expert speaker faculty, session details and more!
What We Saw in 2020:
A Snapshot of Confirmed 2021 Speakers:
Novartis Institutes for Biomedical Research
Professor of Chemistry & Neuroscience
New York University
Chief Scientific Officer
2020 Attendees Included:
“TPD has expanded from a chemical biology tool to a therapeutic modality that redefines the “druggable” target landscape. This meeting will highlight key findings in the field of protein degradation and demonstrate the journey from degrader to therapeutic”
Jay Bradner, President, Novartis Institutes for Biomedical Research